ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Clinical trial NCT07294170 · RECRUITING

Trial details

NCT number: NCT07294170
Sponsor: argenx
Status: RECRUITING
Study type: OBSERVATIONAL

Myasthenia Gravis MG gMG Generalized Myasthenia Gravis Generalized Myasthenia Gravis (gMG)AChR-Ab Seropositive Generalized Myasthenia Gravis

Start date: 2025-12-19
Primary completion: 2028-03-07
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.